Renaissance Technologies
NBP

Renaissance Technologies’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Renaissance Technologies’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
758,226
+485,814
+178% +$991K ﹤0.01% 2131
2026
Q1 		$670K Buy
+272,412
New +$912K ﹤0.01% 2471
2025
Q4 		– Sell
-63,600
Closed -$240K – 3476
2025
Q3 		$240K Sell
63,600
-100
-0.2% -$339 ﹤0.01% 3085
2025
Q2 		$154K Sell
63,700
-100
-0.2% -$136 ﹤0.01% 3220
2025
Q1 		$52.6K Hold
63,800
– – ﹤0.01% 3286
2024
Q4 		$54.2K Hold
63,800
– – ﹤0.01% 3376
2024
Q3 		$79.1K Hold
63,800
– – ﹤0.01% 3294
2024
Q2 		$107K Hold
63,800
– – ﹤0.01% 3171
2024
Q1 		$119K Hold
63,800
– – ﹤0.01% 3337
2023
Q4 		$121K Hold
63,800
– – ﹤0.01% 3257
2023
Q3 		$84K Sell
63,800
-182,508
-74% -$401K ﹤0.01% 3284
2023
Q2 		$736K Buy
246,308
+38,500
+19% +$124K ﹤0.01% 2666
2023
Q1 		$719K Buy
207,808
+160,708
+341% +$778K ﹤0.01% 2679
2022
Q4 		$197K Sell
47,100
-114,000
-71% -$432K ﹤0.01% 3428
2022
Q3 		$646K Buy
+161,100
New +$1.22M ﹤0.01% 2763
2022
Q2 		– Sell
-137,400
Closed -$2.23M – 4391
2022
Q1 		$2.23M Sell
137,400
-87,400
-39% -$2.24M ﹤0.01% 2159
2021
Q4 		$10.7M Buy
224,800
+4,300
+2% +$258K 0.01% 1034
2021
Q3 		$16M Buy
220,500
+44,500
+25% +$3.22M 0.02% 780
2021
Q2 		$14.8M Buy
176,000
+71,900
+69% +$4.74M 0.02% 932
2021
Q1 		$5.05M Sell
104,100
-36,300
-26% -$1.97M 0.01% 1645
2020
Q4 		$6.62M Buy
140,400
+30,400
+28% +$1.2M 0.01% 1416
2020
Q3 		$5.17M Buy
110,000
+86,500
+368% +$2.85M 0.01% 1556
2020
Q2 		$703K Buy
+23,500
New +$486K ﹤0.01% 2723

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies's NBP Position: Q2 2026 in Review

Renaissance Technologies increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 178% in Q2 2026, buying an estimated $991K and bringing the position to 758,226 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Renaissance Technologies first reported a position in NBP in Q2 2020 and has held it in 23 quarters since. The position peaked at $16M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Renaissance Technologies held 758,226 shares of NovaBridge Biosciences American Depositary Shares worth $1.48M as of Q2 2026.
  • Renaissance Technologies bought 485,814 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $991K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2131 holding.
  • Renaissance Technologies first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 23 quarters since.
  • Renaissance Technologies's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.